Evolution of bosutinib (BOS) toxicity in patients (pts) with Ph+ leukemia after resistance/intolerance to prior therapy. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...
Incidence of colorectal premalignant and malignant neoplasm on colonoscopy in an in-patient setting. Bevacizumab (Bev) with or without erlotinib as maintenance therapy, following induction first-line ...
Length of stay is a crucial metric in healthcare management, reflecting the duration a patient occupies a hospital bed. According to the Kenya National Commission of Human Rights, around 25% of ...